T1	Outcomes 607 644	three-year relapse-free survival rate
T2	Outcomes 773 787	adverse events
T3	Outcomes 794 802	relapsed
T4	Outcomes 812 829	died of toxicity.
T5	Outcomes 941 950	relapsed.
T6	Outcomes 993 1002	relapsed.
T7	Outcomes 1017 1048	localized lymphoblastic disease
